XML 22 R19.htm IDEA: XBRL DOCUMENT
v3.19.3

EARNINGS PER COMMON SHARE | 9 Months Ended
--- | ---
Sep. 30, 2019
EARNINGS PER COMMON SHARE |
EARNINGS PER COMMON SHARE | 13. EARNINGS PER COMMON SHARE The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):
|  | Three Months Ended |  | Nine Months Ended
|  | September 30, |  | September 30,
|  | 2019 |  | 2018 |  | 2019 |  | 2018
Basic: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (63,284) |  | $ | (81,837) |  | $ | (1,040,687) |  | $ | (100,709)
Weighted average basic number of common shares outstanding |  |  | 159,143 |  |  | 158,011 |  |  | 158,916 |  |  | 156,628
Basic net income (loss) per share of common stock |  | $ | (0.40) |  | $ | (0.52) |  | $ | (6.55) |  | $ | (0.64)
Diluted: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (63,284) |  | $ | (81,837) |  | $ | (1,040,687) |  | $ | (100,709)
Weighted average basic number of common shares outstanding |  |  | 159,143 |  |  | 158,011 |  |  | 158,916 |  |  | 156,628
Common stock equivalent shares representing shares issuable upon: |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive
Exercise of warrants |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive
Vesting of restricted shares |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive |  |  | Anti-dilutive
Weighted average diluted number of common shares outstanding |  |  | 159,143 |  |  | 158,011 |  |  | 158,916 |  |  | 156,628
Diluted net income (loss) per share of common stock |  | $ | (0.40) |  | $ | (0.52) |  | $ | (6.55) |  | $ | (0.64)
Common stock equivalents, including stock options, restricted shares and warrants totaling 11.8 million and 14.1 million shares for the three and nine months ended September 30, 2019, respectively, were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the net losses. Common stock equivalents, including stock options, restricted shares and warrants totaling 14.9 million and 14.3 million shares for the three and nine months ended September 30, 2018, respectively, were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the net losses. On the Effective Date, all shares of the predecessor company were cancelled, see Note 15, “Subsequent Events” for further details related to the impact of emergence from chapter 11 bankruptcy on the Company’s common stock outstanding.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration